-
Fulvestrant (ICI 182,780) Workflow Guide
2026-08-28
Build reproducible ERα-antagonism experiments with Fulvestrant (ICI 182,780), from stock preparation and dose finding to MDM2 protein degradation and chemotherapy-sensitization assays. A reference-study translation also shows how the same antagonist can help dissect estrogen-linked immune and endoplasmic-reticulum-stress pathways without overstating cross-domain evidence.
-
Protease Inhibitor Cocktail: Assay Guide
2026-08-28
Learn how Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO), SKU K1010, supports more reliable protein-based endpoints in viability, proliferation, and cytotoxicity workflows. This scenario-driven guide covers compatibility, dosing, interpretation, and practical product selection.
-
Hyperoside, DHX9, and R-Loop Control in URSA
2026-08-27
This study identifies a mechanistic link between endometrial stromal cell senescence, unresolved R-loops, DHX9 dysfunction, and cGAS–STING activation in unexplained recurrent spontaneous abortion. By integrating patient tissues, a mouse model, and a human stromal-cell system, the authors show that hyperoside reduces embryo resorption and improves decidualization-associated defects, providing a framework for studying genome-integrity mechanisms in URSA.
-
Procainamide Hydrochloride Research Workflows
2026-08-27
Build reproducible cardiac, epigenetic, immunomodulatory, and combination-therapy assays around a well-characterized sodium channel modulator. Practical guidance covers concentration design, liposomal co-delivery, assay controls, and troubleshooting for stronger mechanistic conclusions.
-
iPSC Models of Schizophrenia and Bipolar Disorder
2026-08-26
This resource study established and characterized three human iPSC lines from two cousins diagnosed with schizophrenia or bipolar disorder and an unaffected cousin. The family-linked panel provides a practical platform for investigating neurodevelopmental mechanisms, although disease-specific phenotypes still require neural differentiation and functional validation.
-
RNA Pol II Loss Activates Apoptosis Beyond Transcription
2026-08-26
Harper et al. show that RNA polymerase II inhibition kills cells through active apoptotic signaling triggered by depletion of hypophosphorylated RNA Pol IIA, rather than through passive loss of transcriptional output. Their PDAR framework links RNA Pol II degradation to mitochondrial death signaling and offers a mechanistic lens for interpreting transcription-targeting drugs.
-
FITC-Concanavalin A (ConA) Conjugate Guide
2026-08-25
FITC-Concanavalin A (ConA) Conjugate is a direct fluorescent probe for accessible α-D-glucose and α-D-mannose residues on glycoproteins and glycolipids. It supports cell-surface carbohydrate detection, tissue imaging, and flow cytometry, but should not be used as a universal glycan stain or as a probe for non-carbohydrate targets.
-
Sodium Citrate for Smarter SERS Assay Design
2026-08-25
Explore how Sodium citrate can shape solution chemistry without being mistaken for the structural driver of 3D SERS performance. This evidence-led guide connects citrate buffering and chelation with polymer pen lithography, assay controls, and reproducibility decisions.
-
Phenytoin: Sodium Channels and Myelin Assays
2026-08-24
Phenytoin, also known as 5,5-diphenylimidazolidine-2,4-dione, is a research compound used to study voltage-gated sodium channel modulation and neuronal excitability. Recent work shows that neuronal activity can worsen early myelin swelling, but it does not establish phenytoin as a myelin-repair treatment.
-
Triacetin Workflows for Metabolic and Cell Assays
2026-08-24
Triacetin, or glyceryl triacetate, supports cell-based oncology studies, metabolic experiments, and ocular formulation screening as both a chemical perturbant and formulation component. This practical guide connects dose selection, vehicle controls, aerosol chemistry insights, and troubleshooting for more reproducible life science assays.
-
RRP Restores Lipid Metabolism in Liver Injury
2026-08-23
The reference study shows that Radix Rehmanniae Praeparata extracts reduce hepatic ischemia-reperfusion injury by correcting hepatocyte cholesterol handling, rather than acting only as nonspecific antioxidants. Its mechanistic model connects AMPK–mTOR signaling with suppression of SCAP–SREBP2 cholesterol synthesis and activation of LXRα-dependent cholesterol efflux, providing a useful framework for lipid metabolism research.
-
Fulvestrant: ER Signaling Workflows and Use Cases
2026-08-22
Fulvestrant (ICI 182,780) combines high-affinity ER antagonism with ERα degradation, making it useful for mechanistic studies of endocrine therapy resistance, MDM2 turnover, and chemotherapy response. This workflow also shows how findings from immune and endoplasmic-reticulum-stress research can inform, but not replace, breast cancer assay design.
-
Testosterone Bounce in Degarelix-Treated Prostate Cancer
2026-08-22
This retrospective study identifies testosterone bounce, defined using a 20 ng/dL nadir and maximum threshold, as a prognostic marker for overall and cancer-specific survival in prostate cancer patients receiving degarelix. The findings support serial testosterone assessment as a complementary biomarker strategy, while the absence of a progression-free survival association and the retrospective design limit causal interpretation.
-
FGF4-FGFR1 Signaling Protects Podocytes in DKD
2026-08-21
This Nature Communications study identifies podocyte-secreted FGF4 as an endogenous protector of glomerular integrity in diabetic kidney disease. Genetic loss-of-function, recombinant FGF4 treatment, and human podocyte experiments support an FGFR1–AMPK–FOXO1 mechanism that limits oxidative stress and apoptosis, although translation beyond male mouse models remains to be established.
-
Leupeptin Hemisulfate: Translational Control
2026-08-20
Leupeptin hemisulfate salt is more than a broad protease inhibitor: it is a mechanistic tool for connecting protease activity regulation with protein degradation studies, viral replication inhibition, and autophagy interpretation. This thought-leadership perspective outlines how to use Leupeptin, Microbial strategically, while applying the direct-binding and functional-validation principles demonstrated in a recent TET2 metabolite-regulation protocol.